Hubert Walinski
Director/Board Member at CIPHER PHARMACEUTICALS INC.
Net worth: - $ as of 2024-04-29
Hubert Walinski active positions
Companies | Position | Start | End |
---|---|---|---|
CIPHER PHARMACEUTICALS INC. | Director/Board Member | 2023-06-20 | - |
Independent Dir/Board Member | 2023-06-20 | - | |
Aic Global Holdings, Inc. | Chief Tech/Sci/R&D Officer | 2021-07-31 | - |
Career history of Hubert Walinski
Former positions of Hubert Walinski
Companies | Position | Start | End |
---|---|---|---|
AstraZeneca Canada, Inc.
AstraZeneca Canada, Inc. Pharmaceuticals: MajorHealth Technology AstraZeneca Canada, Inc. develops and manufactures pharmaceutical drug preparations. Its therapeutic areas include cardiovascular and metabolic disease, oncology, and respiratory, inflammation and autoimmunity. The firm also active in the infection, neuroscience and gastrointestinal disease areas. The company was founded in 1999 and is headquartered in Mississauga, Canada. | Chief Tech/Sci/R&D Officer | 2015-12-31 | 2021-06-30 |
Training of Hubert Walinski
University of British Columbia | Doctorate Degree |
McMaster University | Undergraduate Degree |
Statistics
International
Canada | 6 |
Operational
Chief Tech/Sci/R&D Officer | 2 |
Director/Board Member | 1 |
Independent Dir/Board Member | 1 |
Sectoral
Health Technology | 3 |
Consumer Services | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Listed companies | 1 |
---|---|
CIPHER PHARMACEUTICALS INC. | Health Technology |
Private companies | 2 |
---|---|
Aic Global Holdings, Inc. | |
AstraZeneca Canada, Inc.
AstraZeneca Canada, Inc. Pharmaceuticals: MajorHealth Technology AstraZeneca Canada, Inc. develops and manufactures pharmaceutical drug preparations. Its therapeutic areas include cardiovascular and metabolic disease, oncology, and respiratory, inflammation and autoimmunity. The firm also active in the infection, neuroscience and gastrointestinal disease areas. The company was founded in 1999 and is headquartered in Mississauga, Canada. | Health Technology |
- Stock Market
- Insiders
- Hubert Walinski
- Experience